Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2018 | 3 |
2020 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Life events and treatment prognosis for depression: A systematic review and individual patient data meta-analysis.
J Affect Disord. 2022 Feb 15;299:298-308. doi: 10.1016/j.jad.2021.12.030. Epub 2021 Dec 14.
J Affect Disord. 2022.
PMID: 34920035
Free PMC article.
Review.
The value of an embedded qualitative study in a trial of a second antidepressant for people who had not responded to one antidepressant: understanding the perspectives of patients and general practitioners.
Chew-Graham CA, Shepherd T, Burroughs H, Dixon K, Kessler D.
Chew-Graham CA, et al.
BMC Fam Pract. 2018 Dec 14;19(1):197. doi: 10.1186/s12875-018-0877-4.
BMC Fam Pract. 2018.
PMID: 30547766
Free PMC article.
Clinical Trial.
Item in Clipboard
Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
Kessler D, Burns A, Tallon D, Lewis G, MacNeill S, Round J, Hollingworth W, Chew-Graham C, Anderson I, Campbell J, Dickens C, Macleod U, Gilbody S, Davies S, Peters TJ, Wiles N.
Kessler D, et al.
Health Technol Assess. 2018 Nov;22(63):1-136. doi: 10.3310/hta22630.
Health Technol Assess. 2018.
PMID: 30468145
Free PMC article.
Clinical Trial.
Item in Clipboard
Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR).
Kessler DS, MacNeill SJ, Tallon D, Lewis G, Peters TJ, Hollingworth W, Round J, Burns A, Chew-Graham CA, Anderson IM, Shepherd T, Campbell J, Dickens CM, Carter M, Jenkinson C, Macleod U, Gibson H, Davies S, Wiles NJ.
Kessler DS, et al.
BMJ. 2018 Oct 31;363:k4218. doi: 10.1136/bmj.k4218.
BMJ. 2018.
PMID: 30381374
Free PMC article.
Clinical Trial.
Item in Clipboard
Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial.
Tallon D, Wiles N, Campbell J, Chew-Graham C, Dickens C, Macleod U, Peters TJ, Lewis G, Anderson IM, Gilbody S, Hollingworth W, Davies S, Kessler D.
Tallon D, et al.
Trials. 2016 Feb 3;17:66. doi: 10.1186/s13063-016-1199-2.
Trials. 2016.
PMID: 26842107
Free PMC article.
Clinical Trial.
Item in Clipboard
Does anxiety moderate the effectiveness of mirtazapine in patients with treatment-resistant depression? A secondary analysis of the MIR trial.
Rifkin-Zybutz R, MacNeill S, Davies SJ, Dickens C, Campbell J, Anderson IM, Chew-Graham CA, Peters TJ, Lewis G, Wiles N, Kessler D.
Rifkin-Zybutz R, et al.
J Psychopharmacol. 2020 Dec;34(12):1342-1349. doi: 10.1177/0269881120965939. Epub 2020 Nov 4.
J Psychopharmacol. 2020.
PMID: 33143538
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite